APA (7th ed.) Citation

Tandaric, L., Auranen, A., Kleinmanns, K., Christensen, R. D., Thomsen, L. C. V., Wogsland, C. E., . . . Bjørge, L. Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO‐OV‐UMB1/ENGOT‐OV30 trial. Wiley.

Chicago Style (17th ed.) Citation

Tandaric, Luka, et al. Peripheral Blood Leukocyte Signatures as Biomarkers in Relapsed Ovarian Cancer Patients Receiving Combined Anti‐CD73/anti‐PD‐L1 Immunotherapy in Arm A of the NSGO‐OV‐UMB1/ENGOT‐OV30 Trial. Wiley.

MLA (9th ed.) Citation

Tandaric, Luka, et al. Peripheral Blood Leukocyte Signatures as Biomarkers in Relapsed Ovarian Cancer Patients Receiving Combined Anti‐CD73/anti‐PD‐L1 Immunotherapy in Arm A of the NSGO‐OV‐UMB1/ENGOT‐OV30 Trial. Wiley.